Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-06

Clinical Trial Update: Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer [Phase 3]

View source ↗

Summary

This report updates a Phase 3 trial evaluating ultrasound-based treatment for recurrent stage I/II prostate cancer, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: EDAP Technomed | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED